Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 52 publications.

Desai RJ, Wang SV, Sreedhara SK, Zabotka L, Khosrow-Khavar F, Nelson JC, Shi X, Toh S, Wyss R, Patorno E, Dutcher S, Li J, Lee H, Ball R, Dal Pan G, Segal JB, Suissa S, Rothman KJ, Greenland S, Hernan MA, Heagerty PJ, Schneeweiss S. Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center. BMJ. 2024 Feb 12;384:e076460. doi: 10.1136/bmj-2023-076460

Melgar M, Abrams JY, Godfred-Cato S, Shah AB, Garg A, Strunk A, Narasimhan M, Koptyev J, Norden A, Musheyev D, Rashid F, Tannenbaum R, Estrada-Y-Martin RM, Patel B, Karanth S, Achenbach CJ, Hall GT, Hockney SM, Caputo M, Abbo LM, Beauchamps L, Morris SB, Cifuentes RO, de St Maurice A, Bell DS, Prabaker KK, Sanz Vidorreta FJ, Bryant E, Cohen DK, Mohan R, Libby CP, SooHoo S, Domingo TJ, Campbell AP, Belay ED. A multicenter retrospective cohort study to characterize patients hospitalized with MIS-A and COVID-19 in the United States, 2020-2021. Clin Infect Dis. 2023 Nov 17;77(10):1395-405. doi: 10.1093/cid/ciad374

Skajaa N, Adelborg K, Horvath-Puho E, Rothman KJ, Henderson VW, Thygesen LC, Sorensen HT. Labour market participation and retirement after stroke in Denmark: registry based cohort study. BMJ. 2023 Jan 3;380:e072308. doi: 10.1136/bmj-2022-072308

Ahn M, Kang JH, Kim S, Kahangarie D, Nagar SP, Davis KL, Jimenez M, Seo M, Jung M, Sandelin M, Cho BC. Treatment (tx) patterns and outcomes in resectable early-stage NSCLC in South Korea: subgroup analysis of a global real-world (rw) study. Poster presented at the ESMO Asian Congress 2023; December 2, 2023. Singapore, China. [abstract] Ann Oncol. 2023; 34(Suppl 4):S1646-53.

Morris MJ, de Bono J, Nagarajah J, Wei XX, Nordquist T, Koshkin VS, Vickers A, Mirante O, Ghouse R, Tagawa S, Fizazi K. Radiographic progression‑free survival correlation with time‑to‑event endpoints: a post hoc analysis of the VISION trial. Poster presented at the 2022 ESMO Annual Congress; September 9, 2022. Paris, France. [abstract] Ann Oncol. 33(supplement 3):S1170-1. doi: 10.1016/j.annonc.2022.07.1506

Li D, Tan A, Hernandez S, Reilly N, Bussberg CJ, Mansfield C. Patient preferences for unresectable hepatocellular carcinoma (HCC) treatments: balancing overall survival and quality of life. Poster presented at the ESMO 24th World Congress on Gastrointestinal Cancer 2022; June 2022. Barcelona, Spain. [abstract] Ann Oncol. 2022 Jun; 33(Suppl 4):s293.

Ackley SF, Zimmerman SC, Brenowitz WD, Tchetgen Tchetgen EJ, Gold AL, Manly JJ, Mayeda ER, Filshtein TJ, Power MC, Elahi FM, Brickman AM, Glymour MM. Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis. BMJ. 2021 Feb 25;372:n156. doi: 10.1136/bmj.n156

Taylor MH, Leboulleux S, Panaseykin S, Konda B, de La Fouchardiere C, Hughes BGM, Gianoukakis AG, Park YJ, Romanov I, Krzyzanowska MK, Garbinsky D, Sherif B, Pan JJ, Binder TA, Sauter N, Xie R, Brose MS. Health-related quality-of-life (HRQoL) analyses from study 211: a phase 2 study in patients (pts) with radioiodine-refractory differentiated thyroid cancer (RR-DTC) treated with 2 starting doses of lenvatinib (LEN). Poster presented at the 46th Congress of European Society for Medical Oncology (ESMO); September 16, 2021. [abstract] Ann Oncol. 2021; 32(suppl_5):S1205-10. doi: 10.1016/annonc/annonc715

Yland JJ, Bresnick KA, Hatch EE, Wesselink AK, Mikkelsen EM, Rothman KJ, Sorensen HT, Huybrechts KF, Wise LA. Pregravid contraceptive use and fecundability: prospective cohort study. BMJ. 2020 Nov 11;371:m3966. doi: 10.1136/bmj.m3966

Pajouheshnia R, Groenwold RHH, Peelen LM, Reitsma JB, Moons KGM. When and how to use data from randomised trials to develop or validate prognostic models. BMJ. 2019 May 29;356:I2154. doi: 10.1136/bmj.l2154

Obel N, Dessau RB, Krogfelt KA, Bodilsen J, Andersen NS, Moller JK, Roed C, Omland LH, Christiansen CB, Ellermann-Eriksen S, Bangsborg JM, Hansen K, Benfield TL, Rothman KJ, Sorensen HT, Andersen NS, Lebech AM. Long term survival, health, social functioning, and education in patients with European Lyme neuroborreliosis: nationwide population based cohort study. BMJ. 2018 May 30;361:k1998. doi: 10.1136/bmj.k1998

Martin S, Pawer V, Harris N, Gnanasakthy A. Symptoms of gastric cancer from a patient perspective. Poster presented at the ESMO 19th World Congress on Gastrointestinal Cancer; June 28, 2017. Barcelona, Spain. [abstract] Ann Oncol. 2017 Jun; 28(Suppl 3).

Bover I, Colombo N, Korach J, Davis KL, Kaye JK, Lewis IRR, Callejo A, Gasco A. Treatment patterns and BRCA testing practice in platinum-sensitive recurrent serous ovarian cancer: a Spanish medical record review. Poster presented at the 2016 European Society for Medical Oncology Congress; October 7, 2016. Copenhagen, Denmark. [abstract] Ann Oncol. 2016 Oct 11; 27(suppl_6). doi: 10.1093/annonc/mdw374.24

Mikkelsen EM, Riis AH, Wise LA, Hatch EE, Rothman KJ, Cueto HT, Sørensen HT. Alcohol consumption and fecundability: prospective Danish cohort study. BMJ. 2016 Aug 31;354:i4262. doi: 10.1136/bmj.i4262

Casulo C, Day B, Dawson KL, Zhou X, Flowers CR, Farber CM, Hainsworth JD, Cerhan JR, Link BK, Zelenetz AD, Friedberg JW. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study. Ann Oncol. 2015 Nov;26(11):2311-7. doi: 10.1093/annonc/mdv375

Fernandez-Martos C, Garcia-Albeniz X, Pericay C, Maurel J, Aparicio J, Montagut C, Safont MJ, Salud A, Vera R, Massuti B, Escudero P, Alonso V, Bosch C, Martin M, Minsky BD. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial. Ann Oncol. 2015 Aug;26(8):1722-8. doi: 10.1093/annonc/mdv223

Warttig S, Ward S, Rogers G, Guideline Development Group. Diagnosis and management of gallstone disease: summary of NICE guidance. BMJ. 2014 Oct 30;349:g6241. doi: 10.1136/bmj.g6241

Danson S, Andreas S, Chouaid C, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue M, Barth J, Price M, Wolowacz SE, Kaye JA, Kontoudis I. LuCaBIS: a burden of illness study in patients with stage IB-IIIA non-small cell lung cancer in France, Germany and the UK. Poster presented at ESMO (European Society for Medical Oncology) 2014 Congress; September 29, 2014. Madrid, Spain. [abstract] Ann Oncol. 2014 Sep 1; 25(Suppl 4):iv415-6. doi: 10.1093/annonc/mdu347

Mohr P, Harries M, Grange F, Ehness R, Benajmin L, Siakpere O, McLeod LD, Wolowacz SE, Kaye JA, Kontoudis I. Treatment patterns and disease burden of stage IIIB/IIIC melanoma in France, Germany and the UK. Poster presented at the ESMO 2014 Congress; September 28, 2014. Madrid, Spain. [abstract] Ann Oncol. 2014 Sep 1; 25(suppl 4):iv389. doi: 10.1093/annonc/mdu344.40

Gritz ER, Danysh HE, Fletcher FE, Tami-Maury I, Fingeret MC, King RM, Arduino RC, Vidrine DJ. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Infect Dis. 2013 Aug;57(4):608-15. doi: 10.1093/cid/cit349

Nooka AK, Nabhan C, Zhou X, Taylor MD, Byrtek M, Miller TP, Friedberg JW, Zelenetz AD, Link BK, Cerhan JR, Sinha R, Shenoy PJ, Levy D, Dawson K, Hirata JH, Flowers CR. Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices. Ann Oncol. 2013 Feb 1;24(2):441-8.

Juliao PC, Maslanka S, Dykes J, Gaul L, Bagdure S, Granzow-Kibiger L, Salehi E, Zink D, Neligan RP, Barton-Behravesh C, Luquez C, Biggerstaff M, Lynch M, Olson C, Williams I, Barzilay EJ. National outbreak of type a foodborne botulism associated with a widely distributed commercially canned hot dog chili sauce. Clin Infect Dis. 2013 Feb;56(3):376-82. doi: 10.1093/cid/cis901

Zafar SY, Grothey A, Bekaii-Saab T, Bendell J, Sherrill B, Bennett L, Mun Y, Sersch M, Dalal D, Hurwitz HI. Survival among metastatic colorectal cancer (MCRC) patients treated in a randomized controlled trial (RCT) vs an observational cohort study (OCS). Poster presented at the 37th Annual Congress of the European Society for Medical Oncology; September 1, 2012. [abstract] Ann Oncol. 2012 Sep 1; 23(Suppl. 9):191.

Burris H, Beck JT, Rugo H, Baselga J, Lebrun F, Taran T, Bennett L, Ricci J, Sahmoud T, Hortobagyi GN. Health-related quality of life (QoL) in metastatic breast cancer patients treated with everolimus and exemestane versus exemestane monotherapy. Poster presented at the ESMO 2012 Conference; September 2012. [abstract] Ann Oncol. 2012 Sep; 23(Suppl. 9):121-2.

Peeters M, Bennett L, Zhao ZY, Barber B, Zhou X, Zhang J, Xu F, Wiezorek J, Douillard JY. Panitumumab (PMAB) in combination with chemotherapy (CT) versus CT alone: health-related quality of life (HRQOL) in patients (PTS) with wild-type (WT) KRAS metastatic colorectal cancer (MCRC). Poster presented at the European Society for Medical Oncology 13th World Congress on Gastrointestinal Cancers; June 2011. Barcelona, Spain. [abstract] Ann Oncol. 2011 Jun 1; 22(Suppl. 5):v24.

Chirila C, Odom D, Devercelli G, Khan S, Sherif B, Kaye J, Molnar I, Sherrill B. Meta-analysis of the validity of progression-free survival as a surrogate endpoint for overall survival in metastatic colorectal cancer trials. Poster presented at the 35th European Society for Medical Oncology Congress; October 12, 2010. [abstract] Ann Oncol. 2010 Oct; 21(suppl 8):623P.

Martinez C, Assimes TL, Mines D, Dell'aniello S, Suissa S. Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ. 2010 Feb 5;340:c249. doi: 10.1136/bmj.c249

Starke JR, Mucci L, Rothman KJ, Adami HO. Screening for prostate cancer remains controversial. BMJ. 2009 Sep 24;339(7724):b3601.

Sheth AN, Wiersma P, Atrubin D, Dubey V, Zink D, Skinner G, Doerr F, Juliao P, Gonzalez G, Burnett C, Drenzek C, Shuler C, Austin J, Ellis A, Maslanka S, Sobel J. International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice. Clin Infect Dis. 2008 Nov 15;47(10):1245-51. doi: 10.1086/592574.

Mines D, Novelli L. Letter to the editor. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis. 2007 Feb 15;44(4):619-20.

Rubino A, Roskell NS, Tennis P, Mines D, Weich S, Andrews E. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ. 2007 Feb 3;334(7587):242-5.

Richards DA, Boehm KA, Waterhouse DM, Wagener DJ, Krishnamurthi SS, Rosemurgy A, Grove W, Macdonald K, Gulyas S, Clark MJ, Dasse KD. Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study. Ann Oncol. 2006 Jul 1;17:1096-102.

Rothman KJ, Evans S. More on JAMA's policy on industry sponsored studies. BMJ. 2006 Feb 25;332(7539):489.

Rothman KJ, Evans S. Extra scrutiny for industry funded trials. BMJ. 2005 Jan 1;331(7529):1350-1.

Wagner JD, Schwenke DC, Greaves KA, Zhang L, Anthony MS, Blair RM, Shadoan MK, Williams JK. Soy protein with isoflavones, but not an isoflavone-rich supplement, improves arterial low-density lipoprotein metabolism and atherogenesis. Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2241-6.

Allhusen V, Belsky J, Kersey HB, Booth C, Bradley R, Brownell CA, Burchinal M, Caldwell B, Campbell SB, Clarke-Stewart KA, Cox M, Friedman SL, Hirsh-Pasek K, Houts R, Huston A, Jaeger E, Kelly JF, Knoke B, Kochanoff A, Marshall N, McCartney K, McLeod L, Morrison FJ, O'Brien M, Owen MT, Payne C, Phillips D, Pianta R, Robeson WW, Spieker S, Vandell DL, Wallner-Allen KE. Do children's attention processes mediate the link between family predictors and school readiness? Dev Psychol. 2003 Jan 1;39(3):581-93.

Adams MR, Golden DL, Register TC, Anthony MS, Hodgin JB, Maeda N, Williams JK. The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-alpha. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1859-64.

Anthony MS. Phytoestrogens and cardiovascular disease: where's the meat? - Invited editorial. Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1245-7.

Talmud PJ, Hawe E, Miller GJ, Humphries SE. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol. 2002;22(11):1918-23.

Juhan-Vague I, Morange PE, Aubert H, Henry M, Aillaud MF, Alessi MC, Samnegard A, Hawe E, Yudkin J, Margaglione M, di Minno G, Hamsten A, Humphries SE, HIFMECH Study Group. HIFMECH Study Group. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol. 2002;22(5):867-73.

Sorensen HT, Pedersen L, Nogard L, Fonager K, Rothman KJ. Does month of birth affect risk of Crohn's disease in childhood and adolescence? BMJ. 2001 Jan 1;323(7318):907.

Rothman KJ, Michels KB. Declaration of Helsinki should be strengthened. BMJ. 2000 Aug 12;321(7258):442-5.

Sorensen HT, Rothman KJ, Gillman MW, Steffensen FH, Fischer P, Sabroe S. Historical cohort study of in utero exposure to uterotonic drugs and cognitive function in young adult life. BMJ. 1999 Feb;318:433. doi: 10.1136/bmj.318.7181.433

Sorensen HT, Sabroe S, Rothman KJ, Gillman M, Fischer P, Sorensen TIA. Relation between weight and length at birth and body mass index in young adulthood: cohort study. BMJ. 1997 Nov 1;315(7116):1137.

Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2524-31.

Sorensen HT, Sabroe S, Olsen J, Rothman KJ, Gillman MW, Fischer P. Birth weight and cognitive function in young adult life: historical cohort study. BMJ. 1997 Aug 16;315(7105):401-3.

Perez GS, Garcia Rodriguez LA, Castellsague J, Duque OA. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ. 1997 Mar 15;314(7083):796-800.

Henry D, Lim LL, Garcia Rodriguez LA, Perez GS, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ. 1996 Jun 22;312(7046):1563-6.

Rothman KJ. Placebo mania. BMJ. 1996 Jan 1;313(7048):3-4.

Kaplan JR, Adams MR, Anthony MS, Morgan TM, Manuck SB, Clarkson TB. Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2094-100. doi: 10.1161/01.ATV.15.12.2094